Thermo Total Current Liabilities vs Intangible Assets Analysis
TMO Stock | USD 567.98 5.22 0.93% |
Thermo Fisher financial indicator trend analysis is much more than just breaking down Thermo Fisher Scientific prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Thermo Fisher Scientific is a good investment. Please check the relationship between Thermo Fisher Total Current Liabilities and its Intangible Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
Total Current Liabilities vs Intangible Assets
Total Current Liabilities vs Intangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Thermo Fisher Scientific Total Current Liabilities account and Intangible Assets. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Thermo Fisher's Total Current Liabilities and Intangible Assets is 0.8. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of Thermo Fisher Scientific, assuming nothing else is changed. The correlation between historical values of Thermo Fisher's Total Current Liabilities and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Thermo Fisher Scientific are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Total Current Liabilities i.e., Thermo Fisher's Total Current Liabilities and Intangible Assets go up and down completely randomly.
Correlation Coefficient | 0.8 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Total Current Liabilities
Total Current Liabilities is an item on Thermo Fisher balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Thermo Fisher Scientific are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Intangible Assets
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.Most indicators from Thermo Fisher's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Thermo Fisher Scientific current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At this time, Thermo Fisher's Selling General Administrative is very stable compared to the past year. As of the 1st of June 2024, Tax Provision is likely to grow to about 469.3 M, while Discontinued Operations is likely to drop (3.6 M).
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 39.2B | 44.9B | 42.9B | 45.0B | Depreciation And Amortization | 2.1B | 3.7B | 3.4B | 3.6B |
Thermo Fisher fundamental ratios Correlations
Click cells to compare fundamentals
Thermo Fisher Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thermo Fisher fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 58.4B | 69.1B | 95.1B | 97.2B | 98.7B | 103.7B | |
Short Long Term Debt Total | 17.8B | 21.7B | 34.9B | 34.5B | 34.9B | 36.7B | |
Other Current Liab | 2.7B | 4.2B | 5.4B | 5.4B | 4.8B | 5.1B | |
Total Current Liabilities | 6.2B | 10.3B | 13.4B | 17.0B | 14.0B | 14.7B | |
Total Stockholder Equity | 29.7B | 34.5B | 40.8B | 44.0B | 46.7B | 49.1B | |
Property Plant And Equipment Net | 5.4B | 6.7B | 9.9B | 10.9B | 9.4B | 9.9B | |
Net Debt | 15.4B | 11.4B | 30.4B | 26.0B | 26.8B | 28.2B | |
Retained Earnings | 22.1B | 28.1B | 35.4B | 41.9B | 47.4B | 49.7B | |
Cash | 2.4B | 10.3B | 4.5B | 8.5B | 8.1B | 8.5B | |
Non Current Assets Total | 45.2B | 45.5B | 72.0B | 69.7B | 74.1B | 77.8B | |
Non Currrent Assets Other | 1.9B | 2.5B | 4.4B | (2.8B) | 4.0B | 4.2B | |
Cash And Short Term Investments | 2.4B | 10.3B | 4.5B | 8.5B | 8.1B | 8.5B | |
Net Receivables | 5.0B | 6.5B | 8.9B | 9.4B | 8.2B | 8.6B | |
Common Stock Shares Outstanding | 403M | 399M | 397M | 394M | 388M | 272.7M | |
Liabilities And Stockholders Equity | 58.4B | 69.1B | 95.1B | 97.2B | 98.7B | 103.7B | |
Non Current Liabilities Total | 17.1B | 19.1B | 32.1B | 28.8B | 37.9B | 39.8B | |
Inventory | 3.4B | 4.0B | 5.1B | 5.6B | 5.1B | 5.3B | |
Other Current Assets | 1.2B | 1.1B | 1.6B | 1.6B | 3.2B | 3.4B | |
Other Stockholder Equity | 7.1B | 6.0B | 4.9B | 1.6B | 2.1B | 2.0B | |
Total Liab | 28.7B | 34.5B | 54.1B | 53.0B | 51.9B | 54.5B | |
Total Current Assets | 11.9B | 22.0B | 20.1B | 25.2B | 24.6B | 25.8B | |
Short Term Debt | 676M | 2.6B | 2.5B | 5.6B | 3.6B | 3.8B | |
Intangible Assets | 14.0B | 12.7B | 20.1B | 17.5B | 16.7B | 17.5B | |
Accounts Payable | 1.9B | 2.2B | 2.9B | 3.4B | 2.9B | 3.0B | |
Property Plant And Equipment Gross | 4.7B | 5.9B | 12.6B | 14.3B | 15.5B | 16.3B | |
Accumulated Other Comprehensive Income | (2.7B) | (2.8B) | (2.3B) | (3.1B) | (3.2B) | (3.1B) | |
Current Deferred Revenue | 916M | 1.3B | 2.7B | 2.6B | 2.7B | 2.8B | |
Good Will | 25.7B | 26.0B | 41.9B | 41.2B | 44.0B | 46.2B | |
Common Stock Total Equity | 434M | 437M | 439M | 441M | 507.2M | 352.8M | |
Short Term Investments | 10M | 3M | 37M | 28M | 1.8M | 1.7M | |
Common Stock | 434M | 437M | 439M | 441M | 442M | 357.4M | |
Other Liab | 4.8B | 5.1B | 8.1B | 5.7B | 6.5B | 6.9B | |
Other Assets | 1.2B | 1.6B | 3.0B | 2.2B | 2.6B | 2.7B | |
Long Term Debt | 17.1B | 19.1B | 32.3B | 28.9B | 31.3B | 32.9B | |
Treasury Stock | (3.7B) | (5.2B) | (6.8B) | (8.9B) | (8.0B) | (7.6B) | |
Property Plant Equipment | 4.7B | 5.9B | 8.3B | 9.3B | 10.7B | 11.2B | |
Net Tangible Assets | (10.1B) | (4.2B) | (21.2B) | (14.5B) | (13.1B) | (13.7B) | |
Retained Earnings Total Equity | 22.1B | 28.1B | 35.4B | 41.9B | 48.2B | 50.6B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Thermo Stock analysis
When running Thermo Fisher's price analysis, check to measure Thermo Fisher's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Thermo Fisher is operating at the current time. Most of Thermo Fisher's value examination focuses on studying past and present price action to predict the probability of Thermo Fisher's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Thermo Fisher's price. Additionally, you may evaluate how the addition of Thermo Fisher to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is Thermo Fisher's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.042 | Dividend Share 1.44 | Earnings Share 15.59 | Revenue Per Share 110.369 | Quarterly Revenue Growth (0.03) |
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.